Agenda

DAY 1
DAY 2
Session IV
Triple Negative, Continued
Saturday, September 19, 2026
2:30 pm
4:15 pm
Session Moderator(s)
PRESENTATIONS IN THIS SESSION

Session Introduction

Joyce A. O'Shaughnessy, MD

ADCs for Metastatic TNBC: Comparative Efficacy and Safety and Sequencing

Novel ADCs for Metastatic TNBC

Cesar A. Santa-Maria, MD

Management and Prevention of Triple Negative CNS Metastases

MIchelle Melisko, MD

Who are the Metastatic TNBC Exceptional Responders?

Steven Isakoff, MD, PhD

Audience Q&A and Panel Discussion

Joyce A. O'Shaughnessy, MD; Steven Isakoff, MD, PhD; MIchelle Melisko, MD; Cesar A. Santa-Maria, MD